Summit Cancer Centers - North Spokane — Spokane, Washington

Summit Cancer Centers - North Spokane is a clinical research site located in Spokane, Washington, United States 99208.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Summit Cancer Centers - North Spokane has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Non-squamous NSCLC, HER2 Exon 20 Mutation, Hepatocellular Carcinoma.

Sponsors: Jiangsu HengRui Medicine Co., Ltd., Tvardi Therapeutics, Incorporated.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Summit Cancer Centers - North Spokane?

Summit Cancer Centers - North Spokane has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Summit Cancer Centers - North Spokane conducted?

Summit Cancer Centers - North Spokane has 2 clinical trials on record, with 1 currently active. Their work covers Non-squamous NSCLC, HER2 Exon 20 Mutation, Hepatocellular Carcinoma.

Is Summit Cancer Centers - North Spokane accredited by Crixeo Health?

Summit Cancer Centers - North Spokane has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Summit Cancer Centers - North Spokane?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.